Visirna was founded in 2022 in a strategic partnership with Arrowhead Pharmaceuticals (NASDAQ: ARWR). Based in China, with a global vision, Visirna aims to be a leading player in the research and development of oligonucleotide therapeutics. We currently have three first-in-class late clinical-stage siRNA candidates licensed from Arrowhead Pharmaceuticals for the treatment of cardiovascular and metabolic diseases.
We are rapidly advancing our clinical pipelines in an array of trials. Currently, we have one ongoing Phase 3 registration trial in FCS in China, and will soon join multiple MRCT trials for cardiovascular diseases. At the same time, we are also conducting a phase 2 PoC (proof of concept) trial in NASH.
Visirna is setting up a 1500 sqm R&D lab in Suzhou BioBAY to strengthen our existing clinical portfolio for cardiovascular and metabolic diseases. Our goal is to develop a comprehensive treatment repertoire that can effectively address the complex nature of these diseases and provide better outcomes for patients.
Company Details
- Employees
- 20
- Founded
- 2022
- Address
- No. 1788 West Nanjing Road, Jing’an District, Shanghai,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.visirna.com/
- Keywords
- 至本医疗科技（上海）有限公司 OrigiMed.
- HQ
- Shanghai
Visirna Therapeutics Questions
Visirna Therapeutics's website is https://www.visirna.com/
Visirna Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/visirna
Visirna Therapeutics has
20 employees.
View email and phone details for 20
employees at Visirna Therapeutics.
Visirna Therapeutics's industry is
Pharmaceutical Manufacturing
Visirna Therapeutics's top competitors are
博瑞生物医药(苏州)股份有限公司,
Vision Biopharma, Llc,
Arrowhead Pharmaceuticals,
Jiangsu.suqihr.com,
Talent One Consulting,
Xpressions Dance Company,
至本医疗科技（上海）有限公司 Origimed,
Peptifinder Biotech, Inc,
Ionova Life Science,
Juventas Cell Therapy Corp..
Visirna Therapeutics's categories are Pharmaceutical Manufacturing
Visirna Therapeutics's founding year is 2022
